All questions
Dosing and administration: Kisqali (ribociclib) in HR-positive HER2-negative advanced or metastatic breast cancer
7 questions · 3 sources
Dosing and administration questions that apply to every indication of Kisqali are on Kisqali (ribociclib), all indications: Dosing and administration.
Dosing
What is the Kisqali dose for metastatic breast cancer?
How is the Kisqali dose lowered to manage side effects?
Note: The second passage is the advanced or metastatic breast cancer section of Table 1 of the Prescribing Information; each dose level is followed by its number of 200 mg tablets.
How is the Kisqali dose adjusted for QT prolongation?
How is the Kisqali dose adjusted for elevated liver enzymes?
How is the Kisqali dose adjusted for neutropenia?
Treatment combinations
How are the aromatase inhibitor and fulvestrant given with Kisqali?
Treatment duration
How long do patients take Kisqali for metastatic breast cancer?